Management Team

Creating a better future

Pamela Bunes

Chief Executive Officer, Founder

Ms. Bunes has 24 years of medical device history including numerous years with Johnson & Johnson’s Ethicon Endo–Surgery and Biosense Webster, followed by nine years as the senior executive of two start-up companies, one which was a public entity. In 2013 she was a member of the FDA entrepreneur in residence team and currently serves on the operating board of directors for the Yale Entrepreneurial Institute.

Her experience includes sales and sales management, marketing, execution of new product launches, achieving both FDA and CE Mark approval for commercializing new medical technologies, and forming strategic partnerships and alliances through licensing or acquisitions. During the last decade, her market focus has been cardiology and electrophysiology.

She is experienced in raising capital for both private and public companies, and developing innovative medical technologies that improve patient’s lives. Ms. Bunes strives to find a collaborative balance with her team and board of directors, believing that the collective genius of the experience supporting her vision improves the chances of a successful outcome for patients, physicians, and investors.

Colin M. Rolph

Chief Financial Officer

Mr. Rolph has been an angel investor in several start-ups over the past fifteen years. For the past 10 years, Mr. Rolph has been running day to day operations of Tall Oaks Capital, LP and has been CFO of the fund for the past 7 years. Mr. Rolph has also been the CFO of EpiEP, Inc. for the past 3 years and part time CFO of iTiHealth, a start-up out of the University of Virginia for the past two years.

Starting in April of 2014 he is the acting CFO of another start-up out of the University of Virginia, TearSolutions, LLC. Mr. Rolph graduated from the Rochester Institute of Technology in 1982 with a Bachelor of Science.

Michael Theran

VP of Product Development

Mr. Michael Theran is the Vice President of Product Development at EpiEP, Inc. He received his Bachelor of Science in Mechanical Engineering from Boston University.

After starting his career in consumer products as a product designer, product manager then engineering executive, Mr. Theran decided to focus on start-up companies in the life sciences including medical devices. Creating much needed and highly innovative new medical devices from university research has been Mr. Theran’s focus for the last 10 years.

Elsa Abruzzo, RAC, FRAPS

Regulatory Consultant

Elsa has a 25+ year successful regulatory, quality, clinical, and operations track record. Most recently as Founder and CEO of Cygnus Regulatory, her areas of expertise include cardiovascular, neurovascular, orthopedic, CRM, diagnostic imaging, mHealth, Health IT, and point of care diagnostics. Elsa successfully headed numerous project teams at a variety of start-ups. Prior to Cygnus, Ms. Abruzzo worked at companies such as Baxter, Cordis JNJ, CryoLife, Percutaneous Valve Technologies (acquired by Edwards LifeSciences), AtriCure, and Polymer Technology Systems Cardiochek.

Ms. Abruzzo’s regulatory and clinical strategies have resulted in global commercialization of numerous technologies. Some of the disruptive medical solutions Elsa helped bring to market include: transcatheter tissue heart valves, implantable biomaterials, surgical adhesives, embolic agents, stents, atrial fibrillation ablation devices, neuromodulation devices, and point of care analyzers.

Ms. Abruzzo has a B.S. in engineering from the University of Miami (Coral Gables, FL), is regulatory affairs certified (RAC), and a Fellow of the Regulatory Affairs Professional Society (FRAPS). As a thought leader in regulatory, she has been invited to present nationally and was recognized for leadership in Regulatory and Quality by MDDI Magazine 2007.


Q.S. Management

NOVUS Management Group is a technology-startup consulting group that specializes in quality assurance, patent protection, marketing, and software development for the medical device industry. Founded in 2010 by Scott D. Wampler, NOVUS Management Group assists early-stage medical device companies in bringing their products to market by supplying all stages of technology development, patent prosecution, quality control, regulatory support and marketing consultation.

In addition Novus has a dedicated software engineering team to conduct UI/UX GUI design as well as full software development and validation. Based in Cincinnati, Ohio, NOVUS Management Group LLC has assisted over 12 clients through 2013.

Board of Directors

Our industry veterans

Mary Lake Polan, MD, PhD, MPH

Dr. Polan served as the chair of the Department of Obstetrics and Gynecology at Stanford University School of Medicine for over 15 years, and is currently an Adjunct Professor, Department of Obstetrics and Gynecology and Reproductive Sciences at Columbia University School of Medicine.

Dr. Polan served on the board of Wyeth Pharmaceuticals prior to it’s acquisition by Pfizer and currently serves on the board of Quidel Corp, San Diego, CA as well as on the boards of several privately held life sciences companies. She is also a Managing Director of Golden Seeds, an angel investing group which invests in women led companies. In addition, she chairs an SAB in Women’s Health for Proctor and Gamble.

Dr. Polan’s research has involved ovarian and urologic function with many publications in both areas. She is a member of the Institute of Medicine of the National Academy of Sciences and has served on a number of NIH and university committees. She has a long-standing interest in women’s health research and has been actively involved in international public health. She initiated The Eritrean Women’s Project in 2001 and has maintained this surgical project in Eritrea to repair fistulas resulting from traumatic births.

She received her bachelor’s degree from Connecticut College and her Ph.D. in Molecular Biophysics and Biochemistry and M.D. from Yale University and completed her residency and Reproductive Endocrine Fellowship in the Department of Obstetrics and Gynecology at the Yale University School of Medicine. Dr. Polan received her M.P.H. (Maternal and Child Health Program) from the University of California, Berkeley.

Konstantine Drakonakis, Director, Launch Capital

Konstantine is an experienced early stage investor focused on proprietary technologies in the tri-state NY region. As an "Entrepreneurial Engineer", Konstantine gravitates to technology companies within the software, med-tech and green-tech markets. He holds a Masters in Environmental Management from Yale University and a Civil and Environmental Engineering degree from the University of Vermont.

He is a board certified Professional Engineer and is a member of the National Civil Engineering Honors Society. Konstantine lives in New Haven with his wife, 3 year old son and new baby girl. When he can, he finds a Zen moment in his garden.

Thomas K. Brooks

Tom started his medical career at Ethicon Endo Surgery in Sales and moved up into Sales Management in the New York area. He moved to a startup, Meditech, known today as Boston Scientific and held positions in Sales, Sales Management and Business Development.

A few years after the company went public, he left to move to Atlanta as employee number 7 at Novoste Corporation, which went public in 1996. In 2001, Tom moved out to Menlo Park, California to become the President of Conor Medsystems who was developing a novel drug eluding coronary stent and raised over $30 million in capital.

The Company went public in 2004 and was sold to Johnson & Johnson in 2007 for $1.4 billion. In 2003, he formed a venture capital fund, Healthcare Capital Partners, whose primary focus was making seed and early-stage investments in medical device companies.

In 2009 he went back to the west coast to run Mast BioSurgery in San Diego. He returned to Atlanta 2013 and is working on his next start-up company, Vein Closure Systems based in Georgia.

Daniel Wagner, Managing Director, Connecticut Innovations

Dan is responsible for evaluating investment opportunities, structuring new investments and monitoring portfolio companies at Connecticut Innovation. Dan is involved with numerous boards, both as a member and an observer, and has assisted with CI’s investments in Axerion Therapeutics, AxioMx, Affinimark Technologies, CyVek, LiQuifix, Cara Therapeutics and ShopText.

Dan contributes to CI’s expertise in biotech with more than 10 years in the industry. He was previously employed by successful former CI portfolio company CuraGen Corporation. While at CuraGen, Dan held a variety of scientific and operational management positions. His extensive experience in research and development, technology assessment and implementation of next-generation scientific technologies enabled Dan to help transform CuraGen from a genomic and proteomic platform company into a biopharmaceutical firm dedicated to advancing its protein, antibody and small-molecule therapeutics. Dan represents CI on the board of the Crossroads Venture Group.

Dan received his B.S. in Biology from University of Dayton, M.H.S. in Biomedical Sciences from Quinnipiac University, and M.B.A. in Finance from Quinnipiac University.

Dan's favorite things to do are coaching his kids’ sports teams and spending time with family.

Don Crawford

Don is President and Chief Executive Officer of Analytics for Life, Inc. He previously founded and led medical device company Sapheon Inc. from inception to $238M acquisition by Covidien in 2014. His career started with Medtronic and included positions with Guidant, Ventritex, and Intermedics.

Don received his degree in chemical engineering from Georgia Tech and MBA from Emory University.

William E. Sanders, MD, MBA

Gene is a recent medical officer at the FDA’s Office of Device Evaluation, Cardiac Electrophysiology Device Branch.

Dr. Sanders brings an extensive career as a practicing electrophysiologist, medical researcher, and FDA award-winning scientist to EpiEP. Previously, Dr. Sanders was an Associate Professor of Medicine and Pathology at University of North Carolina at Chapel Hill, where he spent 15 years as the Director of Clinical Cardiac Electrophysiology and Pacing and Associate Director of Cardiovascular Diagnostic and Interventional Laboratories. He has been directly involved in the success of multiple start-up medical device companies, acting as a consultant and board member.

Scientific Advisors & Investigators

Our Medical Experts

Principle Investigator and Scientific Advisor

Andrea Natale, MD

FACC, FHRS, FESC, Executive Medical Director, Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Austin, Texas

Scientific Advisors

Vivek Reddy, MD

Mount Sinai School of Medicine, Mount Sinai Hospital, New York, New York, Director of Cardiac Arrhythmia Services, Professor of Medicine, Cardiology, The Leona M. and Harry B Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology

Clinical Investigators

Petr Neužil, MD

Na Holmolce Hospital, Prague, Czech Republic

David Burkhardt, MD

St. David’s Medical Center, Austin, Texas

Luigi Di Biase, MD, PhD

Montefiore Medical Center, New York, New York

Zoltan Csansadi, MD

University of Debrecen, Debrecen, Hungary

Claudio Tondo, MD

Centro Cardiologico Monzino, Milan, Italy

Coronado Carrbucchio, MD

Centro Cardiologico Monzino, Milan, Italy

Antonio Dello Russo, MD

Centro Cardiologico Monzino, Milan, Italy

Miguel Ventura, MD

IdealMed Unidade Hospitalar de Coimbra, Coimbra, Portugal

Douglas Packer, MD

Mayo Clinic, Rochester, Minnesota

Matthew Swale, MD

Mayo Clinic, Rochester, Minnesota

Frédéric Sacher

Hôpital Haut-Lévêque, Bordeaux, France

Pierre Jaïs, MD

Hôpital Haut-Lévêque, Bordeaux, France